Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised

  • Alastair Matheson mail

    Affiliation: Independent Consultant, London, United Kingdom and Toronto, Canada

  • Published: August 09, 2011
  • DOI: 10.1371/journal.pmed.1001072
  • Featured in PLOS Collections

Reader Comments (3)

Post a new comment on this article

Manner of Referencing Undermines Article as a Whole

Posted by BSchwedel on 13 Sep 2011 at 20:00 GMT

I would have liked to see additional references (preferably in the public domain) in this article, especially for several key statements that contain attributions of intent (eg, on page 1/column 2 of the pdf version, "...contributorship listings have acquired unintended parallels with advertising small print, and accordingly are used by industry to reduce its own visibility—despite, ironically, being used as the basis of claims to transparency").

Competing interests declared: Clients of my current employer are pharma companies; I have also worked directly for pharma and am a member of the American Medical Writers Association. However, the opinion expressed here is mine.